Concepedia

Sofía Lachiondo‐Ortega

SL

Statistics

Publications

18

Citations

724

H-Index

15

Active since

2017

Affiliations

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas(Current)

CIC bioGUNE

Ikerbasque

University of the Basque Country

Marqués de Valdecilla University Hospital

Sofía Lachiondo‐Ortega is an author at Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas specializing in life sciences, liver disease, and biochemistry.

ORCID

Publications per year

2017–2024

18

Publications

18

The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury

Lucía Barbier‐Torres, Paula Iruzubieta, David Fernández‐Ramos et al. · Nature Communications · 2017 · 112 citations · Full text

, , +17

Discovery of a Potent and Selective Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with Antifibrotic Activity

Nattawadee Panyain, Aurélien Godinat, Thomas Lanyon‐Hogg et al. · Journal of the American Chemical Society · 2020 · 108 citations · Full text

, , +17

Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression

María Juárez‐Fernández, Naroa Goikoetxea‐Usandizaga, David Porras et al. · Hepatology · 2022 · 63 citations · Full text

, , +17

Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals

Naroa Goikoetxea‐Usandizaga, Marina Serrano‐Maciá, Teresa C. Delgado et al. · Hepatology · 2021 · 61 citations · Full text

, , +17

Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis

Marina Serrano‐Maciá, Jorge Simón, María J. Gonzalez-Rellan et al. · Molecular Metabolism · 2021 · 50 citations · Full text

, , +16

1–5 of 18